ESH/LinkedIn
Mar 3, 2026, 15:16
Transplant vs CAR T Cells in Multiple Myeloma Debate at ESHMM 2026 – ESH
European School of Haematology (ESH) shared a post on LinkedIn:
“Programme Highlight of ESHMM 2026!
Debate 3 – Transplant vs CAR T cells.
Moderated by Martin Kaiser with Mohamad Mohty and Robert Orlowski (with audience voting)
Less than a month to go before the conference begins!
Secure your spot today — Register now and Join us on March 26-28, 2026 in Stockholm, Sweden.
8th Translational Research Conference on Multiple Myeloma.
Conference Chairs: Hartmut Goldschmidt, Martin Kaiser, Suzanne Lentzsch”
Stay updated with Hemostasis Today.
-
Oct 22, 2026, 14:45Seyed Mehrab Safdari: Prenatal Diagnosis in Hemophilia – Two Decades of Progress and Remaining Challenges
-
Oct 22, 2026, 14:39Mahmoud Abdelnabi: Evaluating the Evidence on Elevated Lp(a) and VTE Before Clinical Translation
-
Oct 22, 2026, 14:34David McIntosh: Fundamental Flaws in National Blood Systems Are Root Causes of Failure
-
Oct 22, 2026, 14:32Aurelio Maggio: Bridging Scientific Progress and Equitable Access to SCD Care in Sub-Saharan Africa
-
Oct 22, 2026, 14:26Khaled Musallam: Longevity and Healthy Aging in Thalassemia
-
Oct 22, 2026, 14:26Deise Catamo Vaz: Two Years of Growth and a New Way of Seeing the World of Stroke
-
Oct 22, 2026, 14:24Yara Mohamed: A Silent Killer Plots his Victim’s Death Over Years
-
Oct 22, 2026, 14:19Shailendra Singh: Two Different Pulmonary Embolism Cases, One Critically Important Lesson
-
Oct 22, 2026, 14:14Caitlin Raymond: Estimating Infection Rates After Therapeutic Plasma Exchange in a Large Real-World Population